Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02126163 · ClinicalTrials.gov registry record · NA

Promoting Responsible Drinking: An Internet-based, Interactive Computer Tailored Intervention

A NA study, sponsored by Pro-Change Behavior Systems.

Completed
Registry status
NA
Development phase
1,000
Enrollment target

NCT02126163: Completed NA study, sponsored by Pro-Change Behavior Systems.

NCT02126163 is a NA study that has completed, run by Pro-Change Behavior Systems. The registered enrollment target is 1,000 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02126163, a NA study, has completed, sponsored by Pro-Change Behavior Systems.

COMPLETED
Registry status
NA
Development phase
1,000 participants
Enrollment target

Study Summary

Excessive alcohol use is associated with a range of serious and costly health, social, and economic consequences at the individual and societal level. This program of research serves as a venue by which to produce and test an innovative, science-based, and cost-effective means to intervene in a private, convenient, and individualized way with employed adults who report non-dependent levels of risky drinking. Responsible Drinking offers computer-tailored intervention sessions directed at increasing readiness to limit drinking to national guidelines for low-risk drinking and a complementary dynamic web portal providing additional information, activities, and strategies designed to activate and reinforce the change process. The primary objective is to complete and enhance the development of Responsible Drinking and test it in an effectiveness trial. In Phase II the program capabilities and innovation will expand to integrate the e-Health components (CTI and e-Workbook) with m-Health (mobile health) technologies. The e-Health components will be enhanced to offer a more interactive and engaging user experience. In addition, m-Health technologies (text messaging and mobile device browsing optimization) will be integrated to support engagement in the program and flexible delivery options. 996 employed adults will be recruited to participate in the randomized trial. The treatment group will receive three intervention sessions during the course of six months and group differences on a number of outcomes will be evaluated at 12 and 18 month follow-up assessments.

Primary Outcome

To assess efficacy by comparing treatment and control group participants who are at-risk at baseline - assessed using a self-report Transtheoretical Model of Behavior Change (TTM) stage of change measure

Interventions

  • BEHAVIORAL Treatment Group

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2014-04
Est. Completion 2016-03
Phase NA
Pro-Change Behavior Systems

11 total trials

What the finished NCT02126163 record still lists

NCT02126163 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower).

The record links to 0 conditions, and to 1 intervention - of which Treatment Group is the first listed.

NCT02126163 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02126163 about?

NCT02126163 is a clinical study titled "Promoting Responsible Drinking: An Internet-based, Interactive Computer Tailored Intervention". Excessive alcohol use is associated with a range of serious and costly health, social, and economic consequences at the individual and societal level. This program of research serves as a venue by which to produce and test an innovative, science-based, and cost-effective means to intervene in a priv...

What is the current status of trial NCT02126163?

This trial is currently completed. It is a NA study. The enrollment target is 1,000 participants. The study started on 2014-04. Estimated completion is 2016-03.

What interventions are being tested in trial NCT02126163?

The interventions under investigation include: Treatment Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT02126163?

This trial is sponsored by Pro-Change Behavior Systems, which has 11 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02126163's enrollment target sits among peer trials

1,000 107th of 2000 higher than 1,880 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02126163, the US trial registry maintained by the National Library of Medicine. NCT02126163 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.